Deaths in Gambia must be a wake-up call for India
- The deaths are the latest example of the ineffectiveness of a regulatory system that has stymied the efforts of earnest reformers.
The heart-breaking loss of 66 children’s lives in Gambia due to adulterated cough syrup manufactured by a Haryana-based pharmaceutical company has triggered a much-needed debate on India’s drug regulators. But, will anything change?
Select your Category
Login to enjoy exclusive benefits!
- Unlocked premium articles
- Personalized news
- Market Watchlist
- Insightful Newsletters & more